2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 20.017 | 20.665 | 20.393 | 29.477 | 31.805 | 49.364 | 37.164 | 51.465 | 45.839 | 56.257 |
Total Income - EUR | 20.024 | 20.668 | 26.352 | 29.477 | 31.805 | 49.364 | 37.164 | 51.465 | 47.175 | 56.257 |
Total Expenses - EUR | 28.406 | 28.336 | 27.060 | 37.066 | 33.709 | 40.368 | 36.354 | 37.646 | 40.664 | 44.721 |
Gross Profit/Loss - EUR | -8.383 | -7.667 | -708 | -7.589 | -1.904 | 8.996 | 809 | 13.819 | 6.511 | 11.536 |
Net Profit/Loss - EUR | -8.984 | -8.284 | -972 | -7.880 | -2.316 | 8.503 | 443 | 13.304 | 6.339 | 10.985 |
Employees | 5 | 6 | 6 | 7 | 6 | 5 | 6 | 7 | 6 | 3 |
Check the financial reports for the company - Bioxid 96 Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 21.009 | 26.154 | 25.887 | 25.449 | 25.063 | 24.577 | 24.111 | 23.577 | 23.650 | 23.578 |
Current Assets | 18.643 | 18.053 | 17.764 | 20.474 | 24.775 | 28.153 | 39.841 | 57.015 | 89.484 | 82.605 |
Inventories | 205 | 904 | 2.642 | 674 | 1.183 | 321 | 2.976 | 0 | 499 | 0 |
Receivables | 14.997 | 15.399 | 13.676 | 16.097 | 20.570 | 22.271 | 20.332 | 42.077 | 65.396 | 38.948 |
Cash | 3.441 | 1.751 | 1.446 | 3.704 | 3.022 | 5.560 | 16.533 | 14.938 | 23.589 | 43.657 |
Shareholders Funds | 4.440 | 1.163 | 134 | -7.748 | -9.921 | -1.227 | -760 | 12.601 | 29.500 | 47.765 |
Social Capital | 45 | 45 | 0 | 0 | 0 | 0 | 0 | 40 | 0 | 40 |
Debts | 35.212 | 43.045 | 43.517 | 53.672 | 59.759 | 53.956 | 64.713 | 67.991 | 83.634 | 58.418 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4778 - 4778" | |||||||||
CAEN Financial Year |
4676
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Bioxid 96 Srl